Table 1 General characteristics of the patients
From: Risk factors for paclitaxel-induced peripheral neuropathy in patients with breast cancer
Age (year) | 45.76 (10.73)* |
≤ 40, n (%) | 21 (37) |
41–50, n (%) | 19 (33) |
51+, n (%) | 17 (30) |
Body mass index (kg/m2) | 45.07(8.86)* |
≤ 42.95, n (%) | 30 (53) |
42.96+, n (%) | 27 (47) |
Body surface area (m2) | 1.73 (.21)* |
PIPN** n (%) | |
None | 33 (58%) |
Mild | 14 (24%) |
Moderate | 9 (16%) |
Severe | 1 (2%) |
Estrogen receptor positive (%) | 52 |
Progesterone receptor (%) | 54 |
P53 negative (%) | 70 |
HER2 negative (%) | 79 |
Grade (1, 2, 3) (%) | 17, 53, 30 |